Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Ruiz

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitorsAdam Golebiowski, R Paul Beckett, Michael Van Zandt, et al.
Communications Chemistry|April 29, 2023
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitorsXiangyi Jiang, Boshi Huang, Shawn Rumrill, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based ApproachMahta Mansouri, Shawn Rumrill, Shane Dawson, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reactionAdam Golebiowski, Darren Whitehouse, R Paul Beckett, et al.
Journal of Medicinal Chemistry|March 12, 2013
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injuryMichael C Van Zandt, Darren L Whitehouse, Adam Golebiowski, et al.
The European Physical Journal. E, Soft Matter|July 11, 2019
European Space Agency experiments on thermodiffusion of fluid mixtures in spaceM Braibanti, P -A Artola, P Baaske, et al.
Proteins|September 28, 2021
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitorsAdam Golebiowski, R Paul Beckett, Michael Van Zandt, et al.
Communications Chemistry|April 29, 2023
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitorsXiangyi Jiang, Boshi Huang, Shawn Rumrill, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based ApproachMahta Mansouri, Shawn Rumrill, Shane Dawson, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reactionAdam Golebiowski, Darren Whitehouse, R Paul Beckett, et al.
Journal of Medicinal Chemistry|March 12, 2013
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injuryMichael C Van Zandt, Darren L Whitehouse, Adam Golebiowski, et al.
The European Physical Journal. E, Soft Matter|July 11, 2019
European Space Agency experiments on thermodiffusion of fluid mixtures in spaceM Braibanti, P -A Artola, P Baaske, et al.
Proteins|September 28, 2021
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Pageof 8